Tracked deals
18
18 tracked deals across 2021-2026.
Nashville, Tennessee, United States
Private equity firm investing in businesses with < $15mm of EBITDA. Focuses on the healthcare and specialty industrial sectors, backing management teams and building businesses.
Tracked deals
18
18 tracked deals across 2021-2026.
Recent pace
4
4 tracked deals announced in the last 12 months.
Deal mix
Addon
13 addon · 2 buyout · 2 divestiture
Last 6 years
Supporting Data
Showing the 12 most recent of 18 tracked deals for Iron Path Capital.
Iron Path Capital-backed CPIhealth acquired Midwest Interventional Spine Specialists (M.I.S.S.) and Serenity Surgical Center to expand its interventional pain management footprint in northwest Indiana and nearby Illinois. The partnership adds two clinics and an ambulatory surgery center (ASC) to CPIhealth’s existing Indiana operations and brings five physicians and two nurse practitioners onto its platform.
PRO-SET Formulated Resin Systems, LLC (a holding of Iron Path Capital) has acquired Universal Chemicals and Coatings, Inc. (UNICHEM), a family-owned manufacturer of industrial coatings, laminating adhesives and container linings. The deal expands PRO-SET’s formulated coatings and laminating adhesive capabilities as an add-on to its growing resin systems platform; financial terms were not disclosed.
PRO-SET Formulated Resin Systems, an Iron Path Capital holding company, has acquired Wessex Resins and Adhesives Ltd., a UK-based manufacturer of high-performance epoxy resins and adhesives. The add-on acquisition expands PRO-SET's composite resins and adhesives capabilities and provides a direct foothold across Europe, the Middle East, Africa and parts of Asia.
PureTech Scientific LLC, a PE-backed specialty glycolic acid manufacturer, has acquired the Dayton, Tennessee operations of Cymer Chemical. The acquisition—backed by PureTech's sponsor Iron Path Capital—adds tolling, blending, organic synthesis and pilot-scale capabilities to PureTech and strengthens its position in life sciences, personal care and specialty industrial end markets.
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.
Versant Diagnostics, a physician services platform backed by Iron Path Capital, has acquired Associate Pathologists of Joliet, Ltd., a multi-specialty pathology practice based in Joliet, Illinois. The deal expands Versant’s nationwide pathology network and increases its presence in the Midwest while enabling additional services and collaboration through Versant’s digital pathology resources.
Capitol Pain Institute (CPI), a PE-backed interventional pain management platform, has acquired Pain Care Surgery of Louisville, an ambulatory surgical center (ASC) in Louisville, Kentucky. The deal — supported by CPI sponsor Iron Path Capital — expands CPI's ability to offer advanced, minimally invasive procedures in Kentucky and strengthens its regional ASC footprint.
Iron Path Capital, a Nashville-based private equity firm, announced a strategic investment in TruTech Servo Motors & Systems as the first platform investment in its industrial automation and motion control build-up strategy. TruTech, a designer and manufacturer of custom permanent magnet servo motors for automation, material handling and medical markets, will receive operational and inorganic support from Iron Path to expand capabilities and enter new end markets.
Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.
PureTech Scientific, a company founded and backed by Iron Path Capital, agreed to acquire The Chemours Company's Glycolic Acid business for $137 million in cash. The transaction (a carve-out/divestiture) closed in August 2023 and creates a standalone platform focused on high‑purity alpha hydroxy acids for life sciences, specialty chemicals and personal care end markets.
Capitol Pain Institute (CPI), a national interventional pain management platform backed by Iron Path Capital, has acquired Balcones Pain Consultants and Water Leaf Surgery Center, adding three clinics and one ambulatory surgical center in the Austin, Texas metropolitan area. The deal expands CPI's presence in Texas and furthers Iron Path Capital's strategy of building a national chronic pain care platform through add-on acquisitions.
Turn tracked acquisition activity into an outreach-ready buyer list.